EN
HI
Summary
As of 20 Sep, 2026, Glenmark Pharmaceuticals stock price is ₹2447.4. During the trading session, the stock has moved between an intraday low of ₹2396.80 and an intraday high of ₹2447.40. Over the last 52 weeks, Glenmark Pharmaceuticals has traded between ₹1792.60 and ₹2537.60.
The stock has recorded a trading volume of 5,45,520 shares,. Its Average Traded Price (ATP) is ₹2419.83, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 288 @ ₹2447.40.
Glenmark Pharmaceuticals has an upper circuit limit of ₹2692.10 and a lower circuit limit of ₹2202.70. The total value traded stands at ₹132.01 CR, and the delivery percentage for the day is 44.53%.
The stock is currently traded with a market lot size of 1. Glenmark Pharmaceuticals also offers a dividend yield of 0.1%.
Glenmark Pharmaceuticals Share Price Chart
Glenmark Pharmaceuticals Share Key Metrics
Volume
5.46 L
Market Cap
69065.83 CR
LTQ@LTP
288@2447.40
ATP
2419.83
Var Margin
14.85 %
Circuit Range
2202.7-2692.1
Delivery %
44.53 %
Value
132.01 CR
ASM/GSM
No
Market Lot
1
Glenmark Pharmaceuticals Fundamentals
P/E Ratio
37.36
P/B Ratio
6.13
Div. Yield
0.1
Sector P/E
42.35
Sector P/B
3.61
Sec. Div. Yield
0.51
Glenmark Pharmaceuticals Resistance and Support
Pivot 2407.1
Resistance
First Resistance
2425.8
Second Resistance
2435.6
Third Resistance
2454.3
Support
First Support
2397.3
Second Support
2378.6
Third Support
2368.8
Glenmark Pharmaceuticals Futures & Options
Glenmark Pharmaceuticals Option Chain
View Price, OI, Greeks & More...
29SEP26
2434.10
18.70 (0.77%)
27OCT26
2442.00
17.10 (0.71%)
23NOV26
2444.00
5.00 (0.21%)
GLENMARK|29SEP26 CE 2440.00
33.00
1.7 (5.43%)
GLENMARK|29SEP26 PE 2460.00
54
-22.2 (-29.13%)
Glenmark Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 18 2026 | 2409.8 | 2447.4 | 1.30% | 2447.4 | 2396.8 |
| Thu Sep 17 2026 | 2406.8 | 2416 | 0.25% | 2416.89 | 2388.39 |
| Wed Sep 16 2026 | 2371.69 | 2410 | 1.62% | 2425.8 | 2306.3 |
Glenmark Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-31 | Quarterly Results |
| 2026-05-29 | Audited Results & Final Dividend |
| 2026-01-30 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-09-26 | Interim Dividend |
| 2025-08-14 | Quarterly Results |
| 2025-05-23 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
Glenmark Pharmaceuticals News
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark Pharmaceuticals launched RYALTRIS® Nasal Spray in Brazil for allergic rhinitis treatment. This expands Glenmark's global respiratory footprint into Latin America's largest healthcare market, following Brazilian regulatory approval.
Sep 11 2026 08:50:44
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Credit Rating
Glenmark Pharmaceuticals' long-term bank loan rating was upgraded to 'IND AA+/Stable' by India Ratings. The upgrade reflects improved financial visibility from the ISB 2001 licensing deal and a stronger credit profile.
Sep 11 2026 08:45:20
Read More
Glenmark Pharmaceuticals Management
| Name | Position |
|---|---|
| Rashmi Khandelwal | Company Secretary & Compliance Officer |
| Glenn Saldanha | Chairman & Managing Director |
Glenmark Pharmaceuticals Similar Stocks
Dr. Reddy's Laboratories Ltd.
1185.00
10.00 (0.85%)
Aurobindo Pharma Ltd.
1734.00
44.00 (2.60%)
Manipal Health Enterprises Ltd.
738.95
17.40 (2.41%)
Lupin Ltd.
2083.00
-15.10 (0.72%)
Mankind Pharma Ltd.
2300.70
0.70 (0.03%)
Fortis Healthcare Ltd.
886.00
-0.10 (0.01%)
Aster DM Quality Care Ltd.
755.05
-5.60 (0.74%)
Alkem Laboratories Ltd.
5466.50
118.00 (2.21%)
Biocon Ltd.
385.00
5.00 (1.32%)
Glenmark Pharmaceuticals FAQs
The Buying Price of Glenmark Pharmaceuticals share is 2447.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Glenmark Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Glenmark Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Glenmark Pharmaceuticals shares is 37.36. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Glenmark Pharmaceuticals shares is 6.13. Useful to assess the stock's value relative to its book value.
To assess Glenmark Pharmaceuticals’s valuation compare Sector P/E, P/B which are 42.35 & 3.61 with sector averages, along with growth rates and financial metrics.
The Market Cap of Glenmark Pharmaceuticals is 69065.83 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Glenmark Pharmaceuticals share price is 2537.60 & 1792.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Glenmark Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in GLENMARK
